Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004191446 | SCV003681382 | uncertain significance | not specified | 2021-10-06 | criteria provided, single submitter | clinical testing | The c.475G>C (p.E159Q) alteration is located in exon 2 (coding exon 1) of the IFI44L gene. This alteration results from a G to C substitution at nucleotide position 475, causing the glutamic acid (E) at amino acid position 159 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |